Edmund Wilkins

1.5k total citations
24 papers, 777 citations indexed

About

Edmund Wilkins is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Edmund Wilkins has authored 24 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 12 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Edmund Wilkins's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (12 papers) and HIV/AIDS Research and Interventions (9 papers). Edmund Wilkins is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (12 papers) and HIV/AIDS Research and Interventions (9 papers). Edmund Wilkins collaborates with scholars based in United Kingdom, United States and Spain. Edmund Wilkins's co-authors include Graeme Moyle, P Hay, Geraldine Reilly, Margaret Johnson, Joan Montaner, M. Lois Murphy, Duncan Churchill, Ade Fakoya, Caroline Sabin and Clifford Leen and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Edmund Wilkins

24 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edmund Wilkins United Kingdom 13 604 443 305 154 41 24 777
Teresa Bini Italy 17 622 1.0× 442 1.0× 313 1.0× 278 1.8× 26 0.6× 65 962
Herman G. Sprenger Netherlands 13 624 1.0× 391 0.9× 396 1.3× 223 1.4× 36 0.9× 41 994
Duncan Churchill United Kingdom 17 720 1.2× 543 1.2× 284 0.9× 241 1.6× 44 1.1× 50 1.1k
John Chuah Australia 14 479 0.8× 382 0.9× 281 0.9× 255 1.7× 23 0.6× 18 697
Peter Gute Germany 18 868 1.4× 688 1.6× 216 0.7× 308 2.0× 45 1.1× 35 1.2k
JN Bruun United States 5 937 1.6× 625 1.4× 300 1.0× 380 2.5× 31 0.8× 6 1.1k
María Isabel de José Spain 16 407 0.7× 250 0.6× 278 0.9× 220 1.4× 20 0.5× 47 661
Paola Cicconi Italy 17 489 0.8× 369 0.8× 301 1.0× 351 2.3× 32 0.8× 45 881
Aza Rakhmanova Russia 16 789 1.3× 572 1.3× 247 0.8× 332 2.2× 81 2.0× 42 977
Béatrice Barret France 6 589 1.0× 293 0.7× 337 1.1× 258 1.7× 52 1.3× 6 821

Countries citing papers authored by Edmund Wilkins

Since Specialization
Citations

This map shows the geographic impact of Edmund Wilkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edmund Wilkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edmund Wilkins more than expected).

Fields of papers citing papers by Edmund Wilkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edmund Wilkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edmund Wilkins. The network helps show where Edmund Wilkins may publish in the future.

Co-authorship network of co-authors of Edmund Wilkins

This figure shows the co-authorship network connecting the top 25 collaborators of Edmund Wilkins. A scholar is included among the top collaborators of Edmund Wilkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edmund Wilkins. Edmund Wilkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mugerwa, Henry, Marco Siccardi, Maiara Camotti Montanha, et al.. (2023). Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin. Clinical Infectious Diseases. 78(5). 1246–1255. 6 indexed citations
2.
Warrell, Clare E., Catriona Macrae, Alistair R. D. McLean, et al.. (2021). Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar. BMC Infectious Diseases. 21(1). 375–375. 1 indexed citations
3.
McLean, Alistair R. D., et al.. (2020). Integration of HIV services with primary care in Yangon, Myanmar: a retrospective cohort analysis. HIV Medicine. 21(9). 547–556. 3 indexed citations
4.
Stöhr, Wolfgang, David Dunn, Alejandro Arenas‐Pinto, et al.. (2016). Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy. AIDS. 30(17). 2617–2624. 14 indexed citations
5.
6.
7.
Payne, Brendan, Kieren G. Hollingsworth, Joanne Baxter, et al.. (2014). In Vivo Mitochondrial Function in HIV-Infected Persons Treated with Contemporary Anti-Retroviral Therapy: A Magnetic Resonance Spectroscopy Study. PLoS ONE. 9(1). e84678–e84678. 8 indexed citations
8.
Elion, Richard, Jean‐Michel Molina, José Ramón Arribas, et al.. (2013). A Randomized Phase 3 Study Comparing Once-Daily Elvitegravir With Twice-Daily Raltegravir in Treatment-Experienced Subjects With HIV-1 infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(4). 494–497. 33 indexed citations
9.
Boffito, Marta, Julie Fox, Christine Bowman, et al.. (2013). Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trial. Vaccine. 31(48). 5680–5686. 17 indexed citations
10.
Clayden, Polly, Jyoti Dhar, Yvonne Gilleece, et al.. (2012). British HIV Association guidelines for the management ofHIVinfection in pregnant women 2012. HIV Medicine. 13(S2). 87–157. 88 indexed citations
11.
Taylor, Stephen, Martin Fisher, Sris Allan, et al.. (2011). Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studies. Journal of Antimicrobial Chemotherapy. 67(3). 675–680. 4 indexed citations
12.
Fisher, Martin, Graeme Moyle, Maryam Shahmanesh, et al.. (2009). A Randomized Comparative Trial of Continued Zidovudine/Lamivudine or Replacement With Tenofovir Disoproxil Fumarate/Emtricitabine in Efavirenz-Treated HIV-1-Infected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(5). 562–568. 50 indexed citations
13.
Moyle, Graeme, Caroline Sabin, Jonathan Cartledge, et al.. (2006). A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy. AIDS. 20(16). 2043–2050. 213 indexed citations
14.
15.
Hoggard, Patrick G., Joanne Lloyd, Edmund Wilkins, et al.. (2001). Influence of Prior Exposure to Zidovudine on Stavudine Phosphorylation In Vivo and Ex Vivo. Antimicrobial Agents and Chemotherapy. 45(2). 577–582. 12 indexed citations
16.
Wilkins, Edmund, et al.. (1997). Localized juvenile periodontitis.. PubMed. 17(2). 30–2, 34. 2 indexed citations
17.
Winstanley, Peter, Saye Khoo, Geoffrey Edwards, et al.. (1995). Marked variation in pyrimethamine disposition in AIDS patients treated for cerebral toxoplasmosis. Journal of Antimicrobial Chemotherapy. 36(2). 435–439. 15 indexed citations
18.
Wilkins, Edmund. (1993). Trés difficile. Journal of Infection. 26(1). 1–7. 8 indexed citations
19.
Cope, Andrew P., Jane Anderson, & Edmund Wilkins. (1992). Clostridium difficile toxin-induced reactive arthritis in a patient with chronic Reiter's syndrome. European Journal of Clinical Microbiology & Infectious Diseases. 11(1). 40–43. 19 indexed citations
20.
Anderson, G., et al.. (1979). Fenoterol in asthma. British Journal of Diseases of the Chest. 73(1). 81–84. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teresa Bini Breakdown of academic impact, for papers by Herman G. Sprenger Breakdown of academic impact, for papers by Duncan Churchill Breakdown of academic impact, for papers by John Chuah Breakdown of academic impact, for papers by Peter Gute Breakdown of academic impact, for papers by JN Bruun Breakdown of academic impact, for papers by María Isabel de José Breakdown of academic impact, for papers by Paola Cicconi Breakdown of academic impact, for papers by Aza Rakhmanova Breakdown of academic impact, for papers by Béatrice Barret
Rankless by CCL
2026